Analyst Ratings for Maze Therapeutics (MAZE)
MAZE Rating Summary
MAZE Price Target Summary
- Highest: $110.00 (H.C. Wainwright)
- Lowest: $46.00 (Guggenheim)
- Average: $64.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$64.00 (+149.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/17/2026 | Truist Securities » Updated 4/13/2026 |
Danielle Brill | New Coverage | Buy (N/A) |
64.00 (68.00) |
51.26 (25.68) |
-49.9% | Details |
| 3/10/2026 | Mizuho » Updated 3/25/2026 |
Salim Syed | New Coverage | Outperform (N/A) |
97.00 (N/A) |
44.83 (25.68) |
-42.72% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
